
Sign up to save your podcasts
Or
Dr Bill Nelson and Dr Michael Pishvaian discuss the targeting of KRAS mutations in pancreatic cancer to develop new treatment options for a disease that has been historically difficult to care for.
4.6
99 ratings
Dr Bill Nelson and Dr Michael Pishvaian discuss the targeting of KRAS mutations in pancreatic cancer to develop new treatment options for a disease that has been historically difficult to care for.
823 Listeners
5 Listeners
32,140 Listeners
40 Listeners
24 Listeners
4 Listeners
290 Listeners
112,458 Listeners
56,506 Listeners
325 Listeners
45 Listeners
16 Listeners
2 Listeners
25 Listeners
8,214 Listeners
621 Listeners
58,333 Listeners
156 Listeners
761 Listeners